Banque Cantonale Vaudoise’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66K Buy
11,031
+1,079
+11% +$117K ﹤0.01% 381
2026
Q1
$919K Sell
9,952
-338
-3% -$33.9K 0.03% 394
2025
Q4
$1.05M Sell
10,290
-3,823
-27% -$342K 0.04% 357
2025
Q3
$882K Buy
14,113
+5,779
+69% +$314K 0.03% 374
2025
Q2
$434K Sell
8,334
-248
-3% -$11.1K 0.02% 455
2025
Q1
$366K Buy
+8,582
New +$370K 0.02% 491

Other funds holding GH

Banque Cantonale Vaudoise's GH Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its Guardant Health (GH) stake by 11% in Q2 2026, buying an estimated $117K and bringing the position to 11,031 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #381.

Banque Cantonale Vaudoise first reported a position in GH in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.05M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Banque Cantonale Vaudoise held 11,031 shares of Guardant Health worth $1.66K as of Q2 2026.
  • Banque Cantonale Vaudoise bought 1,079 Guardant Health shares in Q2 2026, an estimated $117K.
  • Guardant Health made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #381 holding.
  • Banque Cantonale Vaudoise first reported a position in Guardant Health in Q1 2025 and has held it in 6 quarters since.
  • Banque Cantonale Vaudoise's Guardant Health position peaked at $1.05M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.